| 1 |
nonalcoholic fatty liver disease
(9440 times)
|
Gastroenterology
(2793 times)
|
NASH (1869 times)
BMI (543 times)
HFD (455 times)
|
1998 Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations.
|
| 2 |
nonalcoholic FLD
(5 times)
|
Gastroenterology
(3 times)
|
FLD (5 times)
AFLD (3 times)
ALD (1 time)
|
2006 Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation.
|
| 3 |
non-alcoholic liver fatty disease
(3 times)
|
Medicine
(1 time)
|
CAD (1 time)
CV (1 time)
IBD (1 time)
|
2013 Nonalcoholic fatty liver in nondiabetic patients with acute coronary syndromes.
|
| 4 |
NAFLD parents
(2 times)
|
Pediatrics
(2 times)
|
---
|
2014 Parental perceptions regarding lifestyle interventions for obese children and adolescents with nonalcoholic fatty liver disease.
|
| 5 |
manifestation-nonalcoholic liver disease
(1 time)
|
Gastroenterology
(1 time)
|
---
|
2015 The Gut Microbiota and Nonalcoholic Fatty Liver Disease.
|
| 6 |
NAFL disease
(1 time)
|
Gastroenterology
(1 time)
|
NAFL (1 time)
NASH (1 time)
TG (1 time)
|
2009 Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis.
|
| 7 |
NAFLD compared with controls
(1 time)
|
Inflammation
(1 time)
|
sCD14 (1 time)
sTNF-RII (1 time)
T2DM (1 time)
|
2010 Elevated endotoxin levels in non-alcoholic fatty liver disease.
|
| 8 |
NAFLD fibrosis score, FibroMeter
(1 time)
|
Gastroenterology
(1 time)
|
APRI (1 time)
LSM (1 time)
|
2016 Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease.
|
| 9 |
NAFLD group
(1 time)
|
Pharmacology
(1 time)
|
BMI (1 time)
HbA1c (1 time)
HOMA (1 time)
|
2018 Analysis of the correlation between non-alcoholic fatty liver disease and bone metabolism indicators in healthy middle-aged men.
|
| 10 |
NAFLD model among various liver diseases compare to control
(1 time)
|
Neoplasms
(1 time)
|
G-CSF (1 time)
|
2017 Granulocyte colony stimulating factor treatment in non-alcoholic fatty liver disease: beyond marrow cell mobilization.
|
| 11 |
NAFLD without HCC
(1 time)
|
Internal Medicine
(1 time)
|
BMI (1 time)
CRP (1 time)
HbA1c (1 time)
|
2017 The Serum Oxidative/Anti-oxidative Stress Balance Becomes Dysregulated in Patients with Non-alcoholic Steatohepatitis Associated with Hepatocellular Carcinoma.
|
| 12 |
non-AFLD
(1 time)
|
Medical Informatics
(1 time)
|
AFLD (1 time)
AUC (1 time)
IMR-MS (1 time)
|
2009 A new ensemble-based algorithm for identifying breath gas marker candidates in liver disease using ion molecule reaction mass spectrometry.
|
| 13 |
non-alcoholic fatty LD
(1 time)
|
Digestive System Diseases
(1 time)
|
LD (1 time)
|
2012 Common Digestive and Liver Diseases among 5880 Patients Admitted to Shariati Hospital,Tehran,Iran during 2000-2009.
|
| 14 |
nonalcoholic steatotic fatty liver disease
(1 time)
|
Medicine
(1 time)
|
AST (1 time)
BMI (1 time)
DM (1 time)
|
2016 The Application of Liver Stiffness Measurement in Residents Without Overt Liver Diseases Through a Community-Based Screening Program.
|
| 15 |
number of HCCs developing on steatosis
(1 time)
|
Biochemistry
(1 time)
|
HCC (1 time)
|
2018 Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment.
|
A Search Service for Abbreviation / Long Form